Tag Archives: NEW DRUG 2013

FDA Approves Ravicti (glycerol phenylbutyrate)for the Chronic Management of Some Urea Cycle Disorders

FDA Approves Ravicti (glycerol phenylbutyrate)for the Chronic Management of Some Urea Cycle Disorders Ravicti is marketed by Hyperion Therapeutics, based in South San Francisco, Calif. February 1, 2013 — The U.S. Food and Drug Administration today approved Ravicti (glycerol phenylbutyrate) … Continue reading

Posted in NEW DRUG 2013 | Tagged | Comments Off on FDA Approves Ravicti (glycerol phenylbutyrate)for the Chronic Management of Some Urea Cycle Disorders